Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Queensland Health
QuintilesIMS
Cerilliant
Johnson and Johnson
Fish and Richardson
Julphar
Citi
Accenture

Generated: June 20, 2018

DrugPatentWatch Database Preview

ZAGAM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Zagam patents expire, and when can generic versions of Zagam launch?

Zagam is a drug marketed by Mylan and is included in one NDA.

The generic ingredient in ZAGAM is sparfloxacin. Additional details are available on the sparfloxacin profile page.
Summary for ZAGAM
Drug patent expirations by year for ZAGAM
Synonyms for ZAGAM
(cis)-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
110871-86-8
111542-93-9
3-Quinolinecarboxylic acid, 1,4-dihydro-5-amino-1-cyclopropyl-6,8-difluoro-7-(3,5-dimethyl-1-piperazinyl)-4-oxo-, cis-
3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-((3R,5S)-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, rel-
3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, cis-
3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-1,4-dihydro-4-oxo-, rel-
5-Amino-1-cyclohexyl-7-(cis-3,5-dimethylpiperazino)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
5-amino-1-cyclopropyl-6,8-difluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)- 6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555
5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid & RU 40555
5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-4-oxo-3-quinolinecarboxylic acid
5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid
5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid
5-azanyl-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-bis(fluoranyl)-4-oxidanylidene-quinoline-3-carboxylic acid
871S868
A802376
AB00639950_03
AB00639950-02
AC-11574
AC1L1TB5
AC1Q29E9
AJ-23393
AK115680
AKOS005622503
AN-33527
API0004214
AT 4140
AT-4140
AX8151779
BB_SC-1127
BBL010957
BDBM50366822
BRN 3658018
C07662
CAS-110871-86-8
CCG-221166
CHEBI:9212
CHEMBL850
CI 978
CI-978
cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
CP 103826
CP-103826
CPD000466312
CS-2347
D00590
D0K6GZ
DB01208
DRG-0143
DSSTox_CID_3590
DSSTox_GSID_23590
DSSTox_RID_77097
DTXSID9023590
DZZWHBIBMUVIIW-DTORHVGOSA-N
Epitope ID:119065
Esparfloxacino
Esparfloxacino [INN-Spanish]
FT-0631055
FT-0674635
HE066359
HE295402
HMS2090N19
HY-B0308
I06-1320
KB-291851
KS-5009
Liposome-encapsulated sparfloxacin
LS-141521
MCULE-1827276157
MFCD00869619
MLS000759417
MolPort-002-507-759
NCGC00159333-02
NCGC00166294-01
NCGC00166294-02
NCGC00166294-03
Parox
PD 1315-1
PD 131501
PD-131501
PD131501
Q90AGA787L
Respipac (TN)
RP-64206
RT-015760
S0896
s1884
SAM001246566
SC-96745
SCHEMBL41311
SMR000466312
Spara
sparcin
sparfloxacin
Sparfloxacin (JAN/USAN/INN)
Sparfloxacin [USAN:BAN:INN:JAN]
Sparfloxacin [USAN:INN:BAN:JAN]
Sparfloxacin & RU 40555
Sparfloxacin trihydrate
Sparfloxacin, >=98.0% (HPLC)
Sparfloxacin, Antibiotic for Culture Media Use Only
sparfloxacin, cis-isomer
Sparfloxacin, VETRANAL(TM), analytical standard
Sparfloxacine
Sparfloxacine [INN-French]
Sparfloxacinum
Sparfloxacinum [INN-Latin]
SPFX
SR-01000759357
SR-01000759357-2
ST24031663
STK802067
Tox21_111580
Tox21_111580_1
UNII-Q90AGA787L
Zagam (TN)
ZINC538362

US Patents and Regulatory Information for ZAGAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan ZAGAM sparfloxacin TABLET;ORAL 020677-001 Dec 19, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Colorcon
Chubb
Fish and Richardson
Federal Trade Commission
Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.